FBIO stock falls 1.91 percent as debt is repaid

Published on 10/07/2026 at 05:20 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

FBIO stock traded at USD 2.05 on October 6, 2026, after Fortress settled USD 15.0 million of debt. Q2 revenue reached USD 18.7 million.

FBIO, US34960Q3074, Illustration mit AI erstellt.

Fortress Biotech stock (ISIN US34960Q3074) was last at USD 2.05 on Nasdaq on October 6, 2026, down 1.91 percent from the prior session. The company repaid the remaining USD 15.0 million under its Oaktree senior secured credit facility on September 30, 2026, according to TradingView.

Debt facility reaches its end

The repayment covered the final principal balance of a USD 50.0 million facility. Fortress also paid USD 435,000 in accrued interest and a USD 150,000 prepayment fee, while the associated liens and security interests were released, TradingView reported on October 1, 2026.

For Fortress, the transaction removes the senior secured claim tied to the agreement and ends the related debt-service obligation. The USD 15.0 million repayment equals 22.0 percent of the companys USD 68.1 million market capitalization as of October 6, 2026, a material balance-sheet event for a small-cap biotechnology company.

Revenue growth adds operating context

Fortress reported second-quarter 2026 revenue of USD 18.7 million, up 14 percent from the prior-year quarter, according to the companys investor-relations materials and the release listing carried by Makkler. Diluted EPS was negative USD 0.08 for the same quarter.

The companys portfolio combines marketed pharmaceutical products with development-stage candidates and equity interests in partner businesses. Fortress lists nine marketed products and multiple development programs, including commercial exposure to ZYCUBO and dermatology products through Journey Medical, according to its investor-relations site.

Shares remain near the yearly low

FBIOs October 6 price of USD 2.05 stood USD 0.05, or 2.5 percent, above its 52-week low of USD 2.00 and USD 2.48 below its 52-week high of USD 4.53. Trading volume was 219,877 shares, compared with an average volume of 512,007 shares.

Market value and investor view

The stock carried a market capitalization of USD 68.1 million on October 6, 2026. The combination of debt repayment, quarterly revenue growth and a share price near the bottom of its yearly range leaves the balance sheet and the next operating update as the key measurable reference points for investors.